Hemo Organic logo

Hemo Organic results

BSE: 524590Commercial Services & SuppliesSmall Cap

Last close ₹22.97₹0.00 (0.00%)

Share price at the BSE close on 19 Oct 2026. Previous close ₹22.97.

52-week range of traded prices to 19 Oct 2026
₹8.25Low, 20 Oct 2025₹24.42High, 14 Jul 2026
Market cap
₹16 Cr4,997th largest listed
P/E
Lossover the last 12 months
P/B
4.9
Dividend yield
Nonein the last 12 months
ROE
−22.5%
ROCE
−9.1%
Debt to equity
0.40
Volume, BSE
5,342

Q2 results, quarter to Sep 2026

Standalone: the listed company alone, without its subsidiaries. ₹ crore.Hemo Organic annual results and balance sheet

Revenue
₹1.43 Cr+14,28,900.0% on a year ago
Operating profit
₹0.01 Cr
Net profit
₹0.01 Cr
Earnings per share
₹0.01
Operating margin
0.4%
Net margin
0.4%

From revenue to net profit, ₹ crore

  1. Revenue1.4
  2. Materials and goods−1.4
  3. Employee costs0.0
  4. Other expenses0.0
  5. Operating profit0.0
  6. Depreciation0.0
  7. Other income0.0
  8. Finance costs0.0
  9. Profit before tax0.0
  10. Tax0.0
  11. Net profit0.0

Hemo Organic results by quarter

Standalone: the listed company alone, without its subsidiaries. Latest quarter to Sep 2026. Results for the quarter to Dec 2026 are due by 14 Feb 2027, 45 days after it ends.Results filings and date

Revenue and net profit by quarter, ₹ crore

  • Revenue
  • Net profit
  • Loss

Operating and net margin by quarter, per cent

  • Operating margin
  • Net margin
₹ croreDec 2021Q3Filed 16 FebMar 2022Q4Filed 3 JunDec 2022Mar 2023Q4Filed 26 MayJun 2023Q1Filed 6 OctSep 2023Q2Filed 25 NovDec 2023Q3Filed 22 FebMar 2024Q4Filed 2 JulJun 2024Q1Filed 20 SepSep 2024Q2Filed 28 OctDec 2024Q3Filed 6 FebMar 2025Q4Filed 12 JunJun 2025Q1Filed 13 AugSep 2025Q2Filed 14 NovDec 2025Q3Filed 13 FebMar 2026Q4Filed 29 MayJun 2026Q1Filed 15 JulSep 2026Q2Filed 17 Oct
Revenue from operations0.000.00–0.000.000.000.000.020.000.000.002.410.000.000.000.930.001.43
0.020.01–0.050.04−0.010.000.230.000.080.132.270.120.040.051.220.071.42
Materials and goods bought0.000.00–0.000.000.000.000.020.000.000.002.200.000.000.000.930.001.40
Employee costs0.010.00–0.000.000.000.000.040.000.010.010.010.030.020.010.010.010.02
Other expenses0.010.00–0.050.04−0.010.000.180.000.070.120.060.090.030.040.290.060.01
Operating profit before depreciation−0.02−0.01–−0.05−0.040.010.00−0.210.00−0.08−0.130.15−0.11−0.04−0.05−0.30−0.070.01
Operating margin–––––––−950.4%–––6.0%−6,021.1%−41,000.0%–−32.0%–0.4%
Depreciation and amortisation0.000.00–0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00
Other income0.000.00–0.000.000.000.000.000.000.000.000.090.000.000.000.000.000.00
Finance costs0.000.00–0.000.000.000.000.020.000.000.000.000.000.000.000.000.000.00
One-off items0.000.00–0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00
Profit before tax−0.02−0.01–−0.05−0.040.010.00−0.230.00−0.08−0.130.24−0.11−0.04−0.05−0.30−0.070.01
0.000.00–0.000.000.000.000.000.000.000.00−0.14−0.03−0.010.110.210.000.00
Tax rate–––––0.0%–––––−58.8%–––––0.0%
Net profit−0.02−0.01–−0.05−0.040.010.00−0.230.00−0.08−0.130.37−0.09−0.03−0.16−0.51−0.070.01
Net margin–––––––−1,031.3%–––15.5%−4,510.5%−30,900.0%–−54.6%–0.4%
Earnings per share−₹0.14––−₹0.15−₹0.12–−₹0.01−₹0.67−₹0.01−₹0.23−₹0.37₹1.08−₹0.25−₹0.09−₹0.45−₹1.46−₹0.21₹0.01
Earnings per share in rupees, restated for later splits and bonuses. No results on record for the quarter to Dec 2022.

Hemo Organic results by half year

Standalone: the listed company alone, without its subsidiaries. The half years to Sep 2022 in the same span that the quarters on record do not fully cover.

₹ croreSep 2022Filed 25 Nov
Revenue from operations0.00
0.01
Materials and goods bought0.00
Employee costs0.00
Other expenses0.01
Operating profit before depreciation0.00
Operating margin−54.2%
Depreciation and amortisation0.00
Other income0.00
Finance costs0.00
One-off items0.00
Profit before tax0.00
Tax0.00
Net profit0.00
Net margin−54.2%
Earnings per share−₹0.01
Earnings per share in rupees, restated for later splits and bonuses.

Filed results, as an XML file each